HIV-1 integrase inhibitor 2
CAS: 957890-42-5
Ref. 3D-HNB89042
1mg | Ausgelaufen | ||
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen | ||
50mg | Ausgelaufen |
Produktinformation
HIV-1 integrase inhibitor 2 is an experimental drug that inhibits HIV-1 integrase. It inhibits the activity of this enzyme by binding to its active site and blocking its ability to catalyze the integration of viral DNA into the host cell's DNA. The compound has a nitro, phenyl ring, and morpholine group that interacts with the enzyme's active site. It also contains a trifluoromethyl group that can interact with the conformation of the enzyme's active site. HIV-1 integrase inhibitor 2 has been shown to act as a competitive antagonist at dopamine receptor subtypes 3 and 4 in experimental studies.